The activation of PI3K/Akt/mTOR signaling is involved in the fibrogenesis in SSc and inhibition of this axis has been shown to exert anti-fibrotic effects in an SSc mouse model [1,5,23]. The gene discussed is AKT1; the disease is systemic sclerosis.